Calendar Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
0.1488 USD -5.82% Intraday chart for Kintara Therapeutics, Inc. +22.57% -12.26%

Chart calendar Kintara Therapeutics, Inc.

71b0ee07ae2c134b6a.cRxWZ27j0DFc_9cKnb719VLuO81iU4ZS210gmQJhSMM.Al0aPwOVqGUul6d989G4lzGFf7xRZPBm9jh__lRMKrMkXTgrOqK1fS6L5w~827fe87b7139309e7c1f42f2b11ef4da

Upcoming events on Kintara Therapeutics, Inc.

15/05/2024 Q3 2024 Earnings Release (Projected)
23/09/2024 Q4 2024 Earnings Release (Projected)
11/11/2024 Q1 2025 Earnings Release (Projected)
18/02/2025 Q2 2025 Earnings Release (Projected)

Past events on Kintara Therapeutics, Inc.

03/04/2024 06:00 pm Business Update Call
15/02/2024 02:37 am Q2 2024 Earnings Release
14/11/2023 02:40 am Q1 2024 Earnings Release
12/10/2023 08:00 pm Dawson James Small Cap Growth Conference
09/10/2023 09:30 pm Extraordinary Shareholders Meeting
05/10/2023 12:00 am LD Micro Main Conference
23/09/2023 08:45 pm European Association for Neuro Oncology Meeting - Abstract No: P11.41.B
19/09/2023 01:55 am Q4 2023 Earnings Release
21/08/2023 08:30 pm Investor Meeting - KOL
09/08/2023 09:30 pm Emerging Growth Conference
19/07/2023 Glioblastoma Awareness Day
21/06/2023 02:00 am Maxim Group Virtual Healthcare Conference
11/05/2023 05:45 pm Q3 2023 Earnings Release
11/05/2023 01:30 am Sidoti Micro-Cap Virtual Conference
08/05/2023 09:30 pm Annual General Meeting
03/05/2023 10:30 pm Aegis Capital Virtual Conference
17/04/2023 11:00 pm American Association for Cancer Research Meeting - Abstract Number: LB126
17/04/2023 11:00 pm American Association for Cancer Research Meeting - Abstract Number: LB127
17/04/2023 11:00 pm American Association for Cancer Research Meeting - Poster Section: 34
17/04/2023 American Association for Cancer Research Meeting - Abstract Number: LB126

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-8,40
-7,25
-15.78%
-9,20
-7,39
-24.41%
-38,2
-31,2
-22.2%
0,00


-14,8
-14,6
-1.05%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,05
-7,22
-11.47%
-9,13
-7,30
-25.08%
-38,3
-39,3
2.47%
0,00


-14,6
-14,6
-0.62%
Net income
Million USD
Released
Forecast
Spread
-8,05
-7,22
-11.47%
-9,13
-7,37
-23.76%
-41,5
-41,1
-1.05%
-22,7


-15,0
-14,9
-0.62%
EPS
USD
Released
Forecast
Spread
-158
-143
-10.49%
-43,5
-29,0
-50%
-80,0
-66,6
-20.08%
-26,0


-9,27
-9,23
-0.43%
Announcement Date09/09/1918/09/2028/09/2127/09/2218/09/23

Quarterly results

Fiscal PeriodJuni 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-5,90
-6,75
12.71%
-5,36
-6,73
20.39%



-3,50
-4,83
27.62%



-3,35
-3,25
-3.2%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,89
-6,72
12.35%
-5,36
-6,73
20.41%



-3,45
-4,83
28.55%



-3,34
-3,25
-2.77%



Net income
Million USD
Released
Forecast
Spread
-5,90
-6,76
12.82%
-5,36
-6,75
20.62%
-4,60


-3,45
-4,83
28.55%
-3,26


-3,34
-3,25
-2.84%



EPS
USD
Released
Forecast
Spread
-6,00
-8,67
30.77%
-5,50
-6,83
19.51%
-3,50


-2,10
-3,50
40%
-1,94


-1,95
-1,93
-1.04%



Announcement Date11/02/2213/05/2209/11/2214/02/2311/05/2318/09/23-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. KTRA Stock
  4. Calendar Kintara Therapeutics, Inc.